U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07772531) titled 'A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder' on Aug. 14.
Brief Summary: A Study to Evaluate BMS-986511 in Adults with Major Depressive Disorder
Study Start Date: Oct. 30
Study Type: INTERVENTIONAL
Condition:
Major Depressive Disorder
Intervention:
DRUG: BMS-986511
Specified dose on specified days
DRUG: Placebo
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Myers Squibb
Disclaimer: Curated by HT Syndication....